Mona Mohamed Watany

6PUBLICATIONS
0CO-AUTHORS
Medical biochemistry - amino acids and metabolitesMolecular targetsCardiology (incl. cardiovascular diseases)Peripheral nervous systemInstrumental methods (excl. immunological and bioassay methods)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Sep 03, 2025
Differential NADP-Dependent Isocitrate Dehydrogenases Expression in Metabolically Healthy Obesity vs Metabolic Syndrome: A Probable Predictive Biomarker for Metabolic Deterioration.

Mona M Watany, Marwa M Elhosary

|Dec 08, 2022
Clinical application of RUBCN/SESN2 mediated inhibition of autophagy as biomarkers of diabetic kidney disease.

Mona M Watany, Hemat E El-Horany, Marwa M Elhosary

|Feb 16, 2022
Correction to: Evaluation of admission levels of P, E and L selectins as predictors for thrombosis in hospitalized COVID-19 patients.

Mona M Watany, Said Abdou, Reham Elkolaly

|Jan 21, 2022
Evaluation of admission levels of P, E and L selectins as predictors for thrombosis in hospitalized COVID-19 patients.

Mona M Watany, Saied Abdou, Reham Elkolaly

|Jun 13, 2018
Nephronectin (NPNT) and the prediction of nephrotic syndrome response to steroid treatment.

Mona Mohamed Watany, Hemat El-Sayed El-Horany

|Jan 06, 2018
Circulating miR-21, miR-210 and miR-146a as potential biomarkers to differentiate acute tubular necrosis from hepatorenal syndrome in patients with liver cirrhosis: a pilot study.

Mona Mohamed Watany, Rasha Youssef Hagag, Hanaa Ibrahim Okda

Pageof 1

Frequent Collaborators